Vitamin D and androgen receptor-targeted therapy for triple-negative breast cancer
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Vitamin D and androgen receptor-targeted therapy for triple-negative breast cancer
Authors
Keywords
Hormone receptor, Triple-negative breast cancer, Androgen receptor, Vitamin D receptor, Cancer stem cells
Journal
BREAST CANCER RESEARCH AND TREATMENT
Volume 157, Issue 1, Pages 77-90
Publisher
Springer Nature
Online
2016-04-27
DOI
10.1007/s10549-016-3807-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Heat shock factor 1 induces cancer stem cell phenotype in breast cancer cell lines
- (2015) Bin Wang et al. BREAST CANCER RESEARCH AND TREATMENT
- Is androgen receptor targeting an emerging treatment strategy for triple negative breast cancer?
- (2015) Aristomenis Anestis et al. CANCER TREATMENT REVIEWS
- Of Mice and Women: A Comparative Tissue Biology Perspective of Breast Stem Cells and Differentiation
- (2015) Gabriela Dontu et al. JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA
- Vitamin D compounds reduce mammosphere formation and decrease expression of putative stem cell markers in breast cancer
- (2015) Joseph Wahler et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Multiple Molecular Subtypes of Triple-Negative Breast Cancer Critically Rely on Androgen Receptor and Respond to Enzalutamide In Vivo
- (2015) V. N. Barton et al. MOLECULAR CANCER THERAPEUTICS
- Inhibition of Mouse Breast Tumor-Initiating Cells by Calcitriol and Dietary Vitamin D
- (2015) Y. Jeong et al. MOLECULAR CANCER THERAPEUTICS
- Utilization of Human Nuclear Receptors as an Early Counter Screen for Off-Target Activity: A Case Study with a Compendium of 615 Known Drugs
- (2015) Fan Fan et al. TOXICOLOGICAL SCIENCES
- Characterization of twenty-five ovarian tumour cell lines that phenocopy primary tumours
- (2015) Tan A. Ince et al. Nature Communications
- Taxonomy of breast cancer based on normal cell phenotype predicts outcome
- (2014) Sandro Santagata et al. JOURNAL OF CLINICAL INVESTIGATION
- Selective Androgen Receptor Modulators (SARMs) Negatively Regulate Triple-Negative Breast Cancer Growth and Epithelial:Mesenchymal Stem Cell Signaling
- (2014) Ramesh Narayanan et al. PLoS One
- Selective androgen receptor modulators as improved androgen therapy for advanced breast cancer
- (2014) Christopher C. Coss et al. STEROIDS
- Amplitude modulation of androgen signaling by c-MYC
- (2013) M. Ni et al. GENES & DEVELOPMENT
- Androgen Receptor Expression and Outcomes in Early Breast Cancer: A Systematic Review and Meta-Analysis
- (2013) F. E. Vera-Badillo et al. JNCI-Journal of the National Cancer Institute
- Effects of enobosarm on muscle wasting and physical function in patients with cancer: a double-blind, randomised controlled phase 2 trial
- (2013) Adrian S Dobs et al. LANCET ONCOLOGY
- Down-Regulation of Vitamin D Receptor in Mammospheres: Implications for Vitamin D Resistance in Breast Cancer and Potential for Combination Therapy
- (2013) Shehla Pervin et al. PLoS One
- The RNA-Binding Protein Musashi-1 Regulates Proteasome Subunit Expression in Breast Cancer- and Glioma-Initiating Cells
- (2013) Chann Lagadec et al. STEM CELLS
- CD49f Enhances Multipotency and Maintains Stemness Through the Direct Regulation of OCT4 and SOX2
- (2012) Kyung-Rok Yu et al. STEM CELLS
- Genomic analysis identifies unique signatures predictive of brain, lung, and liver relapse
- (2011) J. Chuck Harrell et al. BREAST CANCER RESEARCH AND TREATMENT
- Targeting Androgen Receptor in Estrogen Receptor-Negative Breast Cancer
- (2011) Min Ni et al. CANCER CELL
- Aldehyde dehydrogenase: Its role as a cancer stem cell marker comes down to the specific isoform
- (2011) Paola Marcato et al. CELL CYCLE
- The Importance of Stereochemistry on the Actions of Vitamin D
- (2011) G. Chiellini et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Androgen receptor driven transcription in molecular apocrine breast cancer is mediated by FoxA1
- (2011) Jessica L L Robinson et al. EMBO JOURNAL
- Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
- (2011) Brian D. Lehmann et al. JOURNAL OF CLINICAL INVESTIGATION
- The Association between Vitamin D Receptor Expression and Prolonged Overall Survival in Breast Cancer
- (2011) Nina Ditsch et al. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY
- Differential regulation of PTEN expression by androgen receptor in prostate and breast cancers
- (2011) Y Wang et al. ONCOGENE
- Vitamin D Analogs
- (2010) Glenville Jones ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA
- The Role of Vitamin D in Cancer Prevention and Treatment
- (2010) Aruna V. Krishnan et al. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA
- Cancer stem cells: problems for therapy?
- (2010) Malcolm R Alison et al. JOURNAL OF PATHOLOGY
- A Novel Gemini Vitamin D Analog Represses the Expression of a Stem Cell Marker CD44 in Breast Cancer
- (2010) J. Y. So et al. MOLECULAR PHARMACOLOGY
- Drug safety is a barrier to the discovery and development of new androgen receptor antagonists
- (2010) William R. Foster et al. PROSTATE
- Meta-Analysis of Breast Cancer Outcomes in Adjuvant Trials of Aromatase Inhibitors Versus Tamoxifen
- (2009) Mitch Dowsett et al. JOURNAL OF CLINICAL ONCOLOGY
- Vascular Calcification: The Killer of Patients with Chronic Kidney Disease
- (2009) M. Mizobuchi et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Serum Levels of Vitamin D Metabolites and Breast Cancer Risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
- (2008) D. M. Freedman et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Antiproliferative actions of the synthetic androgen, mibolerone, in breast cancer cells are mediated by both androgen and progesterone receptors
- (2008) Elisa J. Cops et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now